VOLTA, Mattia
 Distribuzione geografica
Continente #
NA - Nord America 668
EU - Europa 256
AS - Asia 95
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.022
Nazione #
US - Stati Uniti d'America 668
PL - Polonia 137
CN - Cina 67
UA - Ucraina 43
TR - Turchia 25
DE - Germania 21
IT - Italia 20
GB - Regno Unito 16
FI - Finlandia 9
BE - Belgio 5
SE - Svezia 5
BR - Brasile 2
VN - Vietnam 2
EU - Europa 1
TW - Taiwan 1
Totale 1.022
Città #
Warsaw 136
Woodbridge 99
Fairfield 88
Ann Arbor 49
Seattle 49
Jacksonville 48
Chandler 46
Houston 46
Ashburn 44
Wilmington 39
Cambridge 31
Beijing 26
Izmir 15
Princeton 12
Shanghai 11
San Diego 10
Boardman 8
Falls Church 6
Ferrara 6
Nanjing 6
Brussels 5
Cagliari 4
Milan 4
Bremen 3
Changsha 3
Hebei 3
Jiaxing 3
Redwood City 3
Shenyang 3
Tappahannock 3
Auburn Hills 2
Dearborn 2
Dong Ket 2
Indiana 2
Kunming 2
Mountain View 2
Nanchang 2
New York 2
Frankfurt am Main 1
Haikou 1
Hangzhou 1
Helsinki 1
Jinan 1
Kilburn 1
King Of Prussia 1
London 1
North Wales 1
Norwalk 1
Opole 1
Orange 1
Philadelphia 1
Rancho Santa Margarita 1
San Jose 1
San Mateo 1
Taipei 1
Taizhou 1
Tianjin 1
Verona 1
Walnut 1
Washington 1
Zhengzhou 1
Totale 848
Nome #
Leucine-rich repeat kinase 2, synaptic morphology and motor behavior 184
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 120
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 112
null 108
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release 107
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 98
null 94
null 84
Stimulation of Delta Opioid Receptor and Blockade of Nociceptin/Orphanin FQ Receptor Synergistically Attenuate Parkinsonism 72
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 22
Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice. 16
Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats. New insights into the role of delta receptors in parkinsonism. 15
Totale 1.032
Categoria #
all - tutte 3.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201997 0 0 0 0 0 0 0 0 0 0 41 56
2019/2020283 39 13 12 36 19 26 26 27 22 35 18 10
2020/2021170 16 19 6 22 7 14 18 20 6 18 15 9
2021/2022121 3 20 16 1 9 5 7 7 4 8 12 29
2022/2023109 10 7 8 12 16 15 4 12 15 0 6 4
2023/202444 2 10 2 0 8 6 7 8 1 0 0 0
Totale 1.032